These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
414 related articles for article (PubMed ID: 30269924)
1. Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema: The PeriOcular vs. INTravitreal corticosteroids for uveitic macular edema (POINT) Trial. Thorne JE; Sugar EA; Holbrook JT; Burke AE; Altaweel MM; Vitale AT; Acharya NR; Kempen JH; Jabs DA; Ophthalmology; 2019 Feb; 126(2):283-295. PubMed ID: 30269924 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Noninfectious Uveitic Macular Edema with Periocular and Intraocular Corticosteroid Therapies: A Report by the American Academy of Ophthalmology. Smith JR; Thorne JE; Flaxel CJ; Jain N; Kim SJ; Maguire MG; Patel S; Weng CY; Yeh S; Kim LA Ophthalmology; 2024 Sep; 131(9):1107-1120. PubMed ID: 38647511 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal Therapy for Uveitic Macular Edema-Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results. ; Acharya NR; Vitale AT; Sugar EA; Holbrook JT; Burke AE; Thorne JE; Altaweel MM; Kempen JH; Jabs DA Ophthalmology; 2023 Sep; 130(9):914-923. PubMed ID: 37318415 [TBL] [Abstract][Full Text] [Related]
4. Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results. Tomkins-Netzer O; Lightman S; Drye L; Kempen J; Holland GN; Rao NA; Stawell RJ; Vitale A; Jabs DA; Ophthalmology; 2015 Nov; 122(11):2351-9. PubMed ID: 26359188 [TBL] [Abstract][Full Text] [Related]
5. A pilot study of intravitreal diclofenac versus intravitreal triamcinolone for uveitic cystoid macular edema. Soheilian M; Eskandari A; Ramezani A; Rabbanikhah Z; Soheilian R Ocul Immunol Inflamm; 2013 Apr; 21(2):124-9. PubMed ID: 23697857 [TBL] [Abstract][Full Text] [Related]
6. Twenty-Four Months Follow-Up of Intravitreal Bevacizumab Injection Versus Intravitreal Triamcinolone Acetonide Injection for the Management of Persistent Non-Infectious Uveitic Cystoid Macular Edema. Lasave AF; Schlaen A; Zeballos DG; Díaz-Llopis M; Couto C; El-Haig WM; Arevalo JF Ocul Immunol Inflamm; 2019; 27(2):294-302. PubMed ID: 29157128 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Bae JH; Lee CS; Lee SC Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Dexamethasone Intravitreal Implant with Conventional Triamcinolone in Patients with Postoperative Cystoid Macular Edema. Mylonas G; Georgopoulos M; Malamos P; Georgalas I; Koutsandrea C; Brouzas D; Sacu S; Perisanidis C; Schmidt-Erfurth U; Curr Eye Res; 2017 Apr; 42(4):648-652. PubMed ID: 27612922 [TBL] [Abstract][Full Text] [Related]
9. Bevacizumab versus triamcinolone for persistent diabetic macular edema: a randomized clinical trial. Rodrigues MW; Cardillo JA; Messias A; Siqueira RC; Scott IU; Jorge R Graefes Arch Clin Exp Ophthalmol; 2020 Mar; 258(3):479-490. PubMed ID: 31873786 [TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis: Phase 3 Randomized Trial. Yeh S; Khurana RN; Shah M; Henry CR; Wang RC; Kissner JM; Ciulla TA; Noronha G; Ophthalmology; 2020 Jul; 127(7):948-955. PubMed ID: 32173113 [TBL] [Abstract][Full Text] [Related]
11. Comparison of dexamethasone intravitreal implant and intravitreal triamcinolone acetonide for the treatment of pseudophakic cystoid macular edema in diabetic patients. Dang Y; Mu Y; Li L; Mu Y; Liu S; Zhang C; Zhu Y; Xu Y Drug Des Devel Ther; 2014; 8():1441-9. PubMed ID: 25258512 [TBL] [Abstract][Full Text] [Related]
12. Long-term evaluation of dexamethasone intravitreal implant in vitrectomized and non-vitrectomized eyes with macular edema secondary to non-infectious uveitis. Pelegrín L; de la Maza MS; Molins B; Ríos J; Adán A Eye (Lond); 2015 Jul; 29(7):943-50. PubMed ID: 25998942 [TBL] [Abstract][Full Text] [Related]
13. Suprachoroidal Space Triamcinolone Acetonide: A Review in Uveitic Macular Edema. Fung S; Syed YY Drugs; 2022 Sep; 82(13):1403-1410. PubMed ID: 36018461 [TBL] [Abstract][Full Text] [Related]
14. Suprachoroidal CLS-TA plus Intravitreal Aflibercept for Diabetic Macular Edema: A Randomized, Double-Masked, Parallel-Design, Controlled Study. Barakat MR; Wykoff CC; Gonzalez V; Hu A; Marcus D; Zavaleta E; Ciulla TA Ophthalmol Retina; 2021 Jan; 5(1):60-70. PubMed ID: 32829027 [TBL] [Abstract][Full Text] [Related]
15. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion. Ding X; Li J; Hu X; Yu S; Pan J; Tang S Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319 [TBL] [Abstract][Full Text] [Related]
16. Comparison of intravitreal injection of bevacizumab and triamcinolone acetonide in the treatment of uveitic macular edema. Rahimi M; Shahrzad SS; Banifatemi M Iran J Immunol; 2012 Jun; 9(2):136-44. PubMed ID: 22735801 [TBL] [Abstract][Full Text] [Related]
17. Intravitreal and posterior subtenon triamcinolone acetonide in idiopathic bilateral uveitic macular oedema. Choudhry S; Ghosh S Clin Exp Ophthalmol; 2007 Nov; 35(8):713-8. PubMed ID: 17997773 [TBL] [Abstract][Full Text] [Related]